Cargando…
Phage Lysins for Fighting Bacterial Respiratory Infections: A New Generation of Antimicrobials
Lower respiratory tract infections and tuberculosis are responsible for the death of about 4.5 million people each year and are the main causes of mortality in children under 5 years of age. Streptococcus pneumoniae is the most common bacterial pathogen associated with severe pneumonia, although oth...
Autores principales: | Vázquez, Roberto, García, Ernesto, García, Pedro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232686/ https://www.ncbi.nlm.nih.gov/pubmed/30459750 http://dx.doi.org/10.3389/fimmu.2018.02252 |
Ejemplares similares
-
Sequence-Function Relationships in Phage-Encoded Bacterial Cell Wall Lytic Enzymes and Their Implications for Phage-Derived Product Design
por: Vázquez, Roberto, et al.
Publicado: (2021) -
Phage Products for Fighting Antimicrobial Resistance
por: Huang, Yuanling, et al.
Publicado: (2022) -
Csl2, a novel chimeric bacteriophage lysin to fight infections caused by Streptococcus suis, an emerging zoonotic pathogen
por: Vázquez, Roberto, et al.
Publicado: (2017) -
Phage Therapy: A Different Approach to Fight Bacterial Infections
por: Hibstu, Zigale, et al.
Publicado: (2022) -
Modulation of Macrophage Immunometabolism: A New Approach to Fight Infections
por: Gauthier, Thierry, et al.
Publicado: (2022)